{"product_id":"atryshealth-marketing-mix","title":"Atrys Marketing Mix","description":"\u003cdiv class=\"pr-shrt-dscr-wrapper orange\"\u003e\n\u003csection class=\"pr-shrt-dscr-box\"\u003e\n\u003cdiv class=\"pr-shrt-dscr-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Magnifier-Icon.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGo Beyond the Snapshot—Get the Full Strategy\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"pr-shrt-dscr-content\"\u003e\n\u003cp\u003eDiscover how Atrys blends product innovation, strategic pricing, targeted channels, and persuasive promotion to compete in health-tech and diagnostics; this snapshot highlights key moves and gaps. For a complete, editable 4Ps Marketing Mix with data-driven recommendations and presentation-ready slides, purchase the full report and save hours of research.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter green\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003eroduct\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper green\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003ePrecision diagnostics suite\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003ePrecision diagnostics suite combines comprehensive imaging, pathology and laboratory assays tailored to oncology and complex diseases, emphasizing clinical accuracy and standardized reporting across modalities.\u003c\/p\u003e\n\u003cp\u003eWorkflows are engineered for fast turnaround and regulatory alignment with EU IVDR and international standards to support hospital integration and compliance.\u003c\/p\u003e\n\u003cp\u003eIntegrated multimodal outputs enable earlier detection and therapy selection by synthesizing imaging, molecular and histopathology findings into actionable reports.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eAI-enhanced medical imaging\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eAI-enhanced medical imaging algorithms support triage, segmentation and decision support across radiology modalities, with meta-analyses through 2024 showing ~11% sensitivity gains and ~35% reductions in reading time. They flag high-risk cases for prioritized follow-up, improving patient flow. Seamless PACS\/RIS integration accelerates clinician adoption. Continuous model improvement is driven by validated clinical datasets and real-world feedback cycles.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eRadiation oncology services\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eEnd-to-end treatment planning, dose optimization and delivery in specialized Atrys centers manage radiotherapy workflows for the roughly 50% of cancer patients who require radiation. Multidisciplinary teams coordinate care to improve outcomes and reduce toxicity through shared protocols and timely referrals. Advanced modalities and rigorous quality assurance ensure submillimeter precision while treatment pathways align with evidence-based guidelines.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-green-section\"\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eGenomics and molecular profiling\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eGenomics and molecular profiling: tumor and germline panels guide targeted and immuno-oncology choices, with actionable alterations found in ≈30–40% of advanced tumors; reports map variants to therapies, trials and CPIC\/EU\/ASCO guidelines. High-quality NGS, robust bioinformatics and strict QC deliver TAT ≈7–10 days; supports longitudinal monitoring via liquid biopsy with ctDNA detection rates 70–85% in metastatic disease.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003ePanels: tumor + germline\u003c\/li\u003e\n\u003cli\u003eActionable ≈30–40%\u003c\/li\u003e\n\u003cli\u003eReports → therapies, trials, guidelines\u003c\/li\u003e\n\u003cli\u003eNGS TAT ≈7–10 days\u003c\/li\u003e\n\u003cli\u003ectDNA detection 70–85%\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-green-section4\"\u003e\n\u003cdiv class=\"title-row-green-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eTelemedicine and remote monitoring\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-green-section blur_box\"\u003e\n\u003cp\u003eSecure telemedicine platforms enable virtual consults, follow-ups and chronic care management, with device integration capturing vitals and symptoms for proactive interventions; global telemedicine market ~60 billion USD (2023) and remote monitoring programs cut hospital admissions by ≈20%, improving access in underserved regions and easing hospital burden. Data flows into EMR for continuity of care.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003eSecure virtual consults\u003c\/li\u003e\n\u003cli\u003eDevice integration: vitals \u0026amp; symptoms\u003c\/li\u003e\n\u003cli\u003e≈20% fewer admissions\u003c\/li\u003e\n\u003cli\u003eMarket ≈60B USD (2023)\u003c\/li\u003e\n\u003cli\u003eEMR continuity\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Product-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eIntegrated precision oncology: NGS 7–10d; ctDNA 70–85%; AI +11% sens; telemed −20% admissions\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePrecision oncology product combines imaging, AI, radiotherapy, NGS and telemedicine; NGS TAT 7–10 days, actionable 30–40%, ctDNA 70–85%, AI ~11% sensitivity gain and 35% reading-time reduction. Radiotherapy covers ≈50% of patients with submm precision. Telemedicine cuts admissions ≈20%, market ≈60B USD (2023).\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eFeature\u003c\/th\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eNGS\u003c\/td\u003e\n\u003ctd\u003eTAT \/ Actionable\u003c\/td\u003e\n\u003ctd\u003e7–10d \/ 30–40%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ectDNA\u003c\/td\u003e\n\u003ctd\u003eDetection\u003c\/td\u003e\n\u003ctd\u003e70–85%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eAI\u003c\/td\u003e\n\u003ctd\u003eImpact\u003c\/td\u003e\n\u003ctd\u003e+11% sens, −35% read time\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eRT\u003c\/td\u003e\n\u003ctd\u003eCoverage\u003c\/td\u003e\n\u003ctd\u003e≈50% patients\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelemed\u003c\/td\u003e\n\u003ctd\u003eAdmissions \/ Market\u003c\/td\u003e\n\u003ctd\u003e−20% \/ ≈60B USD\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_orange\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-includes\"\u003e\n\u003ch2\u003eWhat is included in the product\u003c\/h2\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Word-Icon.svg\" alt=\"Word Icon\"\u003e\n\u003cstrong\u003eDetailed Word Document\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eProvides a company-specific deep dive into Atrys’s Product, Price, Place and Promotion strategies, using actual brand practices and competitive context to ground insights. Ideal for managers and consultants—clean, editable layout with examples, positioning and strategic implications for benchmarking, case studies or strategy audits.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"plus-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Plus-Icon.svg\" alt=\"Plus Icon\"\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-includes\"\u003e\n\u003cdiv class=\"title-row-includes\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Excel-Icon.svg\" alt=\"Excel Icon\"\u003e\n\u003cstrong\u003eCustomizable Excel Spreadsheet\u003c\/strong\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-includes\"\u003e\n\u003cp\u003eCondenses Atrys' 4P's into a high-level, at-a-glance summary that clarifies product, price, promotion and placement to resolve stakeholder misalignment and accelerate marketing decisions.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-2_new_design\"\u003e\n\u003cdiv class=\"frst_big_letter_heading\"\u003e\n\u003ch2\u003e\n\u003cspan class=\"frst_big_letter_letter orange\"\u003eP\u003c\/span\u003e\u003cspan class=\"frst_big_letter_text\"\u003elace\u003c\/span\u003e\n\u003c\/h2\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-wrapper orange\"\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eMulti-site clinics and centers\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eOwned and affiliated facilities deliver diagnostics and oncology treatments close to patients through a network of 200+ sites across 8 countries, reducing travel times and improving referral capture. Sites are sited to balance urban demand and regional access, with 60\/40 urban\/regional distribution. Standardized clinical and operational protocols cover 100% of radiology and oncology units to ensure consistent care. Capacity planning matches referral patterns, targeting ~70% average utilization to optimize throughput and margins.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003csection class=\"sub-highlight-box\"\u003e\n\u003cdiv class=\"sub-highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eHospital and provider partnerships\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"sub-highlight-content\"\u003e\n\u003cp\u003eEmbedded services and managed service agreements expand Atrys reach inside hospitals by integrating diagnostics and treatment workflows into existing care pathways. Co-branded pathways align Atrys workflows with provider EHRs and protocols to drive adoption and referral capture. Onsite staff plus 24\/7 remote experts ensure clinical coverage and capacity; SLAs guarantee quality and turnaround times (typically 24–72 hours). \u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-2_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Image.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eDigital and telehealth channels\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003ePatients and clinicians access scheduling, reports and consults online through Atrys digital and telehealth channels, integrated with EMR\/PACS for seamless data exchange and faster report turnaround. Remote triage and second opinions expand access to underserved regions, aligned with telehealth market growth (global market ~60B in 2022, projected strongly through 2027). Cloud delivery leverages the ~$600B public cloud ecosystem (2023) to scale across geographies.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"product-orange-section\"\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eB2B payer and corporate health\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eContracts with insurers, employer health programs and network affiliations drive Atrys clinical volume by channeling steady referrals and bundled payments into diagnostic and telehealth services.\u003c\/p\u003e\n\u003cp\u003ePre-authorization and coding support reduce reimbursement friction, shortening claim cycles and lowering denial risk while improving cash flow for corporate clients.\u003c\/p\u003e\n\u003cp\u003eOccupational and preventive programs generate recurring diagnostic demand; data-sharing and analytics enhance risk stratification and employer cost-management.\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\n\u003cli\u003epayer-contracts\u003c\/li\u003e\n\u003cli\u003epre-authorization\u003c\/li\u003e\n\u003cli\u003eoccupational-health\u003c\/li\u003e\n\u003cli\u003edata-sharing\u003c\/li\u003e\n\u003c\/ul\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"product-box-orange-section4\"\u003e\n\u003cdiv class=\"title-row-orange-section\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-2.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003eLogistics and sample networks\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"content-row-orange-section blur_box\"\u003e\n\u003cp\u003eCourier routes and collection points enable rapid sample transit to labs, with hub-and-spoke lab placement balancing turnaround speed and operational cost; chain-of-custody plus cold-chain protocols preserve specimen integrity while real-time tracking gives providers live status visibility for each shipment.\u003c\/p\u003e\n\u003cp\u003e\u003c\/p\u003e\n\u003cul class=\"lst_crct\"\u003e\u003c\/ul\u003e\n\u003cli\u003eCourier routes \u0026amp; collection points\u003c\/li\u003e\n\u003cli\u003eChain-of-custody \u0026amp; cold-chain\u003c\/li\u003e\n\u003cli\u003eHub-and-spoke lab model\u003c\/li\u003e\n\u003cli\u003eReal-time tracking to providers\u003c\/li\u003e\n\u003c\/div\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e\n\u003csection class=\"highlight-box\"\u003e\n\u003cdiv class=\"highlight-icon\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/MARKETING-MIX-Content-Place-Icon-Color-1.svg\" alt=\"Icon\"\u003e\n\u003ch3\u003e200+ site network across 8 countries: 70% utilization target, 24–72h SLAs, telehealth\/cloud scale\u003c\/h3\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"highlight-content\"\u003e\n\u003cp\u003eOwned network of 200+ sites in 8 countries (60\/40 urban\/regional) optimizes access and referral capture; capacity targets ~70% utilization to balance throughput and margins. Embedded\/MSA and payer contracts (pre-auth support) secure steady referrals; SLAs ensure 24–72h turnaround. Digital\/telehealth integration (telehealth market ~$60B in 2022; public cloud ~$600B in 2023) scales access and reporting.\u003c\/p\u003e\n\u003ctable class=\"tbl_prdct green_head blur_tbl\"\u003e\n\u003cthead\u003e\u003ctr\u003e\n\u003cth\u003eMetric\u003c\/th\u003e\n\u003cth\u003eValue\u003c\/th\u003e\n\u003c\/tr\u003e\u003c\/thead\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd\u003eSites\u003c\/td\u003e\n\u003ctd\u003e200+\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eCountries\u003c\/td\u003e\n\u003ctd\u003e8\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eUrban\/Regional\u003c\/td\u003e\n\u003ctd\u003e60\/40\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTarget utilization\u003c\/td\u003e\n\u003ctd\u003e~70%\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eSLA turnaround\u003c\/td\u003e\n\u003ctd\u003e24–72h\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003eTelehealth market (2022)\u003c\/td\u003e\n\u003ctd\u003e$60B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd\u003ePublic cloud (2023)\u003c\/td\u003e\n\u003ctd\u003e$600B\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cbutton class=\"get_full_prdct_green\" onclick=\"get_full()\"\u003e\u003c\/button\u003e\n\u003c\/div\u003e\n\u003c\/section\u003e\n\u003cdiv class=\"container_new_design\"\u003e\n\u003cdiv class=\"text-section text-1_new_design\"\u003e\n\u003ch2\u003e\n\u003cspan style=\"color: #3BB77E;\"\u003ePreview the Actual Deliverable\u003c\/span\u003e\u003cbr\u003eAtrys 4P's Marketing Mix Analysis\u003c\/h2\u003e\n\u003cp\u003eThe preview shown here is the actual Atrys 4P's Marketing Mix Analysis you'll receive instantly after purchase—no surprises. This is the exact, fully editable and comprehensive document included with your order. Use it immediately for strategy, presentations, or planning. Buy with confidence; this is the final version, not a sample.\u003c\/p\u003e\n\u003c\/div\u003e\n\u003cdiv class=\"image-section image-1_new_design\"\u003e\n\u003cimg src=\"\/cdn\/shop\/files\/GENERAL-Explore-Preview.svg\" alt=\"Explore a Preview\"\u003e\n\u003c\/div\u003e\n\u003c\/div\u003e","brand":"PortersFiveForce","offers":[{"title":"Default Title","offer_id":56164842406265,"sku":"atryshealth-marketing-mix","price":10.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0914\/5276\/8633\/files\/atryshealth-marketing-mix.png?v=1762740751","url":"https:\/\/portersfiveforce.com\/products\/atryshealth-marketing-mix","provider":"Porter's Five Forces","version":"1.0","type":"link"}